Stefania Glieca is currently a PhD student in Professor Francesca Buttini's group at the University of Parma, Italy. The aim of her PhD is the development of dry inhalation powders containing biological products.
In 2021 she obtained a Master's Degree in Pharmaceutical Chemistry and Technology at the University of Parma. The master thesis was focused on the development of a dry inhalation powder containing calcium phosphate coated liposomes with Cyclosporine A for the prevention of lung transplantation rejection and for the treatment of COVID-19.
She started her PhD in “Drug Sciences” in 2022. During her PhD she worked on the formulation of a dry powder formulation for the peripheral lungs delivery of a small anti-SARS-CoV-2 protein that acts as a decoy on the ACE2 receptor.
Her research is currently focused on the formulation of dry powders for inhalation containing Lactobacilli for the modulation and the restoration of the healthy lung microbiota for cystic fibrosis and non-cystic fibrosis bronchiectasis.
She was awarded with the DDL Career Development Grant in 2023 for a project entitled “Development of Lactic Acid Bacteria Inhalation Powders for the Pathogens Infection Containment”.
Photos of Stefania Glieca
